Test Bank_ Pharmacotherapeutics for Advanced
Test Bank_
Practice
Pharmacotherapeutics
5th Edition (Arcangelo)
for Advanced
_ Chapters
Practice
1–56,
5thComplete
Edition (Arcangelo)
Questions &_ Answers
Chapters 1–56, Complete Questions & Answers.pdf 2026-03-10
Test Bank:
Pharmacotherapeutics for
Advanced Practice 5th
Edition (Arcangelo) |
Chapters 1–56, Complete
Questions & Answers
Guidehttps://www.stuvia.com/dashboard!@_)#*)(@$)($@*($@)($@*_
Page 1 of 156 Test Bank_ Pharmacotherapeutics
Page 1 for Advanced Practice 5th Edition (Arcangelo) _ Chapters 1–56, Complete Questions & Answers.pdf
,Test
TestBank
Bankfor
forPharmacotherapeutics
Pharmacotherapeuticsfor
forAdvanced
AdvancedPractice;
Practice;AAPractical
PracticalApproach,
Approach,5th
5thEdition
Editionby
byArcangelo,
Arcangelo,9781975160593,
9781975160593,Covering
CoveringChapters
Chapters
2026-03-10
1-56
1-56.pdf
Page
Test 2Bank
of 156
for Pharmacotherapeutics for Advanced Practice; A Practical Approach,
Page 2 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56.pdf
,Test
TestBank
Bankfor
forPharmacotherapeutics
Pharmacotherapeuticsfor
forAdvanced
AdvancedPractice;
Practice;AAPractical
PracticalApproach,
Approach,5th
5thEdition
Editionby
byArcangelo,
Arcangelo,9781975160593,
9781975160593,Covering
CoveringChapters
Chapters
2026-03-10
1-56
1-56.pdf
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
ANS: A PTS: 1
Page
Test 3Bank
of 156
for Pharmacotherapeutics for Advanced Practice; A Practical Approach,
Page 3 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56.pdf
, Test
TestBank
Bankfor
forPharmacotherapeutics
Pharmacotherapeuticsfor
forAdvanced
AdvancedPractice;
Practice;AAPractical
PracticalApproach,
Approach,5th
5thEdition
Editionby
byArcangelo,
Arcangelo,9781975160593,
9781975160593,Covering
CoveringChapters
Chapters
2026-03-10
1-56
1-56.pdf
Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
MULTIPLE CHOICE
1. A patient’s nutritional intake and lab work reflects hypoalbuminemia. This is critical to
prescribing because:
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney
ANS: A PTS: 1
2. Drugs that have a significant first-pass effect:
A. Must be given by the enteral (oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms
ANS: C PTS: 1
3. The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
ANS: B PTS: 1
4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of the
drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and active
D. Are most common in collagen tissues
ANS: C PTS: 1
5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects
ANS: B PTS: 1
6. Azithromycin dosing requires the first day’s dose be twice those of the other 4 days of the
prescription. This is considered a loading dose. A loading dose:
A. Rapidly achieves drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
Page
Test 4Bank
of 156
for Pharmacotherapeutics for Advanced Practice; A Practical Approach,
Page 4 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56.pdf
Test Bank_
Practice
Pharmacotherapeutics
5th Edition (Arcangelo)
for Advanced
_ Chapters
Practice
1–56,
5thComplete
Edition (Arcangelo)
Questions &_ Answers
Chapters 1–56, Complete Questions & Answers.pdf 2026-03-10
Test Bank:
Pharmacotherapeutics for
Advanced Practice 5th
Edition (Arcangelo) |
Chapters 1–56, Complete
Questions & Answers
Guidehttps://www.stuvia.com/dashboard!@_)#*)(@$)($@*($@)($@*_
Page 1 of 156 Test Bank_ Pharmacotherapeutics
Page 1 for Advanced Practice 5th Edition (Arcangelo) _ Chapters 1–56, Complete Questions & Answers.pdf
,Test
TestBank
Bankfor
forPharmacotherapeutics
Pharmacotherapeuticsfor
forAdvanced
AdvancedPractice;
Practice;AAPractical
PracticalApproach,
Approach,5th
5thEdition
Editionby
byArcangelo,
Arcangelo,9781975160593,
9781975160593,Covering
CoveringChapters
Chapters
2026-03-10
1-56
1-56.pdf
Page
Test 2Bank
of 156
for Pharmacotherapeutics for Advanced Practice; A Practical Approach,
Page 2 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56.pdf
,Test
TestBank
Bankfor
forPharmacotherapeutics
Pharmacotherapeuticsfor
forAdvanced
AdvancedPractice;
Practice;AAPractical
PracticalApproach,
Approach,5th
5thEdition
Editionby
byArcangelo,
Arcangelo,9781975160593,
9781975160593,Covering
CoveringChapters
Chapters
2026-03-10
1-56
1-56.pdf
Chapter 1 Issues for the Practitioner in Drug Therapy
MULTIPLE CHOICE
1. Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy
ANS: C PTS: 1
2. Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners
ANS: D PTS: 1
3. Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process
C. Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs
ANS: A PTS: 1
4. Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
prescribing
ANS: B PTS: 1
5. Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level
ANS: A PTS: 1
Page
Test 3Bank
of 156
for Pharmacotherapeutics for Advanced Practice; A Practical Approach,
Page 3 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56.pdf
, Test
TestBank
Bankfor
forPharmacotherapeutics
Pharmacotherapeuticsfor
forAdvanced
AdvancedPractice;
Practice;AAPractical
PracticalApproach,
Approach,5th
5thEdition
Editionby
byArcangelo,
Arcangelo,9781975160593,
9781975160593,Covering
CoveringChapters
Chapters
2026-03-10
1-56
1-56.pdf
Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic
MULTIPLE CHOICE
1. A patient’s nutritional intake and lab work reflects hypoalbuminemia. This is critical to
prescribing because:
A. Distribution of drugs to target tissue may be affected
B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney
ANS: A PTS: 1
2. Drugs that have a significant first-pass effect:
A. Must be given by the enteral (oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms
ANS: C PTS: 1
3. The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin
ANS: B PTS: 1
4. Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage reservoir of the
drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and active
D. Are most common in collagen tissues
ANS: C PTS: 1
5. The NP chooses to give cephalexin every 8 hours based on knowledge of the drug’s:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects
ANS: B PTS: 1
6. Azithromycin dosing requires the first day’s dose be twice those of the other 4 days of the
prescription. This is considered a loading dose. A loading dose:
A. Rapidly achieves drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
Page
Test 4Bank
of 156
for Pharmacotherapeutics for Advanced Practice; A Practical Approach,
Page 4 5th Edition by Arcangelo, 9781975160593, Covering Chapters 1-56.pdf
